首站-论文投稿智能助手
典型文献
Fish ACE2 is not susceptible to SARS-CoV-2
文献摘要:
Dear Editor, The ongoing pandemic of coronavirus disease 2019(COVID-19)has reshaped our daily life and caused>4 million deaths worldwide().Although lockdown and vaccination have improved the situation in many countries,imported cases and sporadic outbreaks pose a constant stress to the prevention and control of COVID-19.Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),the etiologic agent responsible for COVID-19,has a positive-sense single-stranded RNA genome of 30 kb(Coronaviridae Study Group of the In-ternational Committee on Taxonomy of Viruses,2020).
文献关键词:
作者姓名:
Shi-Zhe Xie;Mei-Qin Liu;Ren-Di Jiang;Hao-Feng Lin;Wei Zhang;Bei Li;Jia Su;Fei Ke;Qi-Ya Zhang;Zheng-Li Shi;Xing-Lou Yang
作者机构:
CAS Key Laboratory of Special Pathogens,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China;University of Chinese Academy of Sciences,Beijing,100049,China;State Key Laboratory of Freshwater Ecology and Biotechnology,Institute of Hydrobiology,Chinese Academy of Sciences,Wuhan,430072,China
文献出处:
引用格式:
[1]Shi-Zhe Xie;Mei-Qin Liu;Ren-Di Jiang;Hao-Feng Lin;Wei Zhang;Bei Li;Jia Su;Fei Ke;Qi-Ya Zhang;Zheng-Li Shi;Xing-Lou Yang-.Fish ACE2 is not susceptible to SARS-CoV-2)[J].中国病毒学,2022(01):142-144
A类:
B类:
Fish,ACE2,not,susceptible,SARS,CoV,Dear,Editor, The,ongoing,pandemic,coronavirus,disease,has,reshaped,our,daily,life,caused,million,deaths,worldwide,Although,lockdown,vaccination,have,improved,situation,many,countries,imported,cases,sporadic,outbreaks,pose,constant,stress,prevention,control,Severe,acute,respiratory,syndrome,etiologic,agent,responsible,positive,sense,single,stranded,genome,kb,Coronaviridae,Study,Group,In,ternational,Committee,Taxonomy,Viruses
AB值:
0.826214
相似文献
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
Yao Zhao;Chao Fang;Qi Zhang;Ruxue Zhang;Xiangbo Zhao;Yinkai Duan;Haofeng Wang;Yan Zhu;Lu Feng;Jinyi Zhao;Maolin Shao;Xiuna Yang;Leike Zhang;Chao Peng;Kailin Yang;Dawei Ma;Zihe Rao;Haitao Yang-Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Bioorganic&Natural Products Chemistry,Center for Excellence in Molecular Synthesis,Shanghai Institute of Organic Chemistry,University of Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai 200032,China;CAS Center for Excellence in Molecular Cell Science,Shanghai Institute of Biochemistry and Cell Biology,Chinese Academy of Sciences,Shanghai 200031,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;National Facility for Protein Science in Shanghai,Zhangjiang Lab,Shanghai Advanced Research Institute,Chinese Academy of Sciences,Shanghai 201210,China;Taussig Cancer Center,Cleveland Clinic,Cleveland,OH 44195,USA;Laboratory of Structural Biology,School of Life Sciences and School of Medicine,Tsinghua University,Beijing 100091,China;State Key Laboratory of Medicinal Chemical Biology,Frontiers Science Center for Cell Response,College of Life Sciences,Nankai University,and Tianjin Key Laboratory of Protein Sciences,Tianjin 300071,China
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Na-Na Zhang;Rong-Rong Zhang;Yi-Fei Zhang;Kai Ji;Xiao-Chuan Xiong;Qian-Shan Qin;Peng Gao;Xi-Shan Lu;Hang-Yu Zhou;Hai-Feng Song;Bo Ying;Cheng-Feng Qin-Department of Virology,State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Academy of Military Medical Sciences,Beijing,China;School of Medicine,Tsinghua University,Beijing,China;Kunming University of Science and Technology,Kunming,Yunnan,China;Suzhou Abogen Biosciences Co.,Ltd.,Suzhou,Jiangsu,China;School of Life Sciences,Fujian Agriculture and Forestry University,Fuzhou,Fujian,China;Institute of Systems Medicine,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China;Research Unit of Discovery and Tracing of Natural Focus Diseases,Chinese Academy of Medical Sciences,Beijing,China
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
Mengjiao Li;Zi-Wei Ye;Kaiming Tang;Liang Guo;Wenwen Bi;Yuyuan Zhang;Yan-dong Tang;Guoguang Rong;Mohamad Sawan;Xin Yin;Ren Sun;Shuofeng Yuan;Bobo Dang-Fudan University,Shanghai,China;Key Laboratory of Structural Biology of Zhejiang Province,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Center for Infectious Disease Research,Westlake Laboratory of Life Sciences and Biomedicine,Hangzhou,Zhejiang,China;Institute of Biology,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;Department of Microbiology,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Emerging Infectious Diseases,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin,China;CenBRAIN Lab.,School of Engineering,Westlake University,Hangzhou,Zhejiang,China;CenBRAIN Lab.,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;School of Biomedical Sciences,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Jun Lan;Xinheng He;Yifei Ren;Ziyi Wang;Huan Zhou;Shilong Fan;Chenyou Zhu;Dongsheng Liu;Bin Shao;Tie-Yan Liu;Qisheng Wang;Linqi Zhang;Jiwan Ge;Tong Wang;Xinquan Wang-The Ministry of Education Key Laboratory of Protein Science,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,Collaborative Innovation Center for Biotherapy,School of Life Sciences,Tsinghua University,Beijing,China;Microsoft Research Asia,Beijing,China;Shanghai Synchrotron Radiation Facility,Shanghai Advanced Research Institute,Chinese Academy of Sciences,Shanghai,China;Department of Chemistry,Tsinghua University,Beijing,China;Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center,and Beijing Advanced Innovation Center for Structural Biology,School of Medicine,Tsinghua University,Beijing,China
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants,including Omicron sublineages
Lei Wang;Wangjun Fu;Linlin Bao;Zijing Jia;Yuxia Zhang;Yunjiao Zhou;Wei Wu;Jianbo Wu;Qianqian Zhang;Yidan Gao;Kang Wang;Qiao Wang;Chuan Qin;Xiangxi Wang-CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,China;University of Chinese Academy of Sciences,Beijing,China;Key Laboratory of Human Disease Comparative Medicine,Chinese Ministry of Health,Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;Changping Laboratory,Beijing,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Shanghai Institute of Infectious Disease and Biosecurity,Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu;Yuhua Li;Zhongfang Wang;Shouchun Cao;Weijin Huang;Lin Yuan;Yi-Jiao Huang;Yan Zheng;Jingjing Chen;Bo Ying;Zuoyun Xiang;Jin Shi;Jincun Zhao;Zhen Huang;Cheng-Feng Qin-Yunnan Province Centre for Disease Control and Prevention,Kunming,Yunnan,China;National Institutes for Food and Drug Control,Beijing,China;Respiratory Medicine,Guangzhou Institute of Respiratory Health,Guangzhou,Guangdong,China;Walvax Biotechnology Co.,Ltd.,Kunming,Yunnan,China;State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Academy of Military Medical Sciences,Beijing,China;Suzhou Abogen Biosciences Co.,Ltd,Suzhou,Jiangsu,China;Research Unit of Discovery and Tracing of Natural Focus Diseases,Chinese Academy of Medical Sciences,Beijing,China
Omicron-specific mRNA vaccine elicits potent immune responses in mice,hamsters,and nonhuman primates
Yi Wu;Yanqiong Shen;Namei Wu;Xinghai Zhang;Shaohong Chen;Chang Yang;Junhui Zhou;Yan Wu;Da Chen;Li Wang;Chao Wang;Huajun Zhang;Ninuo Xia;Sandra Chiu;Yucai Wang-Department of Radiology,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;School of Basic Medical Sciences,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;University of Chinese Academy of Sciences,Beijing,China;MOE Key Laboratory for Cellular Dynamics,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;RNAIfa Biotech,Hefei,Anhui,China
mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2
Yuxuan Han;Yaling An;Qian Chen;Kun Xu;Xueyuan Liu;Senyu Xu;Huixin Duan;Annette B.Vogel;Ugur ?ahin;Qihui Wang;Lianpan Dai;George F.Gao-Savaid Medical School,University of Chinese Academy of Sciences,Beijing,China;Institutes of Physical Science and Information Technology,Anhui University,Hefei,Anhui,China;CAS Key Laboratory of Pathogen Microbiology and Immunology,Institute of Microbiology,Chinese Academy of Sciences,Beijing,China;Research Network of Immunity and Health(RNIH),Beijing Institutes of Life Science,Chinese Academy of Sciences,Beijing,China;Key Laboratory of Tropical Translational Medicine of Ministry of Education,School of Tropical Medicine and Laboratory Medicine,The First Affiliated Hospital,Hainan Medical University,Haikou,Hainan,China;School of Public Health,Cheeloo College of Medicine,Shandong University,Jinan,Shandong,China;BioNTech SE,Mainz,Germany
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。